Oral anti-parasitic composition

US11497785B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11497785-B2
Application numberUS-201414917021-A
CountryUS
Kind codeB2
Filing dateSep 5, 2014
Priority dateSep 6, 2013
Publication dateNov 15, 2022
Grant dateNov 15, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a composition for use as an oral anti-parasitic, the composition comprises one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus Cinnamomum, Eugenia, Eucalyptus or a source of saponin. It also relates to a method of preventing or treating parasitic infection in an animal, the method comprising orally administering to said animal a composition comprising one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus Cinnamomum, Eugenia, Eucalyptus or a source of saponin.

First claim

Opening claim text (preview).

The invention claimed is: 1. A pet consumable comprising a single oral anti-parasitic composition, the single oral anti-parasitic composition consisting of a source of saponin, an essential oil of oregano and an essential oil from genus Cinnamomum or from genus Eugenia , wherein the essential oil of oregano and the essential oil from genus Cinnamomum or Eugenia are present in the anti-parasitic composition in a ratio of from 4:1 to 1:4, and wherein the anti-parasitic composition exhibits a greater proliferation inhibition with respect to Neospora caninum or Toxoplasma gondii than the combined proliferation inhibition of the individual components. 2. The pet consumable of claim 1 , wherein the source of saponin contains a steroid sapogenin. 3. The pet consumable of claim 1 , wherein the consumable is a foodstuff, and wherein the foodstuff comprises 70% to 90% moisture. 4. The pet consumable of claim 1 , wherein the consumable is in the form of a liquid. 5. The pet consumable of claim 1 , wherein the consumable is a foodstuff, and wherein the foodstuff comprises 5% to 15% moisture. 6. The pet consumable of claim 5 , wherein the foodstuff comprises 10-40% protein or 5-40% fat. 7. The pet consumable of claim 6 , wherein the foodstuff is in the form of a biscuit. 8. The pet consumable of claim 5 , wherein the consumable is in the form of a tablet. 9. An anti-parasitic composition, consisting of an essential oil of oregano and an essential oil from genus Cinnamomum or genus Eugenia , and optionally, a source of saponin, wherein the essential oil of oregano and the essential oil from genus Cinnamomum or Eugenia are present in the anti-parasitic composition in a ratio of from 4:1 to 1:4, and wherein the anti-parasitic composition exhibits a greater proliferation inhibition with respect to Neospora caninum or Toxoplasma gondii than the combined proliferation inhibition of the individual components. 10. The pet consumable of claim 9 , wherein the single oral parasitic composition consists of an essential oil of oregano and an essential oil from genus Cinnamomum or genus Eugenia. 11. A method of preventing or treating parasitic infection in an animal, the method comprising orally administering to said animal an anti-parasitic composition consisting of a source of saponin, an essential oil of oregano and an essential oil from genus Cinnamomum , or from genus Eugenia , wherein the essential oil of oregano and the essential oil from genus Cinnamomum or Eugenia are present in the anti-parasitic composition in a ratio of from 4:1 to 1:4 and wherein the composition exhibits a greater proliferation inhibition with respect to Neospora caninum or Toxoplasma gondii than the combined proliferation inhibition of the individual components.

Assignees

Inventors

Classifications

  • A61K36/61Primary

    Myrtaceae (Myrtle family), e.g. teatree or eucalyptus · CPC title

  • Lauraceae (Laurel family), e.g. cinnamon or sassafras · CPC title

  • Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin · CPC title

  • Antiparasitic agents · CPC title

  • Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11497785B2 cover?
The present invention relates to a composition for use as an oral anti-parasitic, the composition comprises one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus Cinnamomum, Eugenia, Eucalyptus or a source of saponin. It also relates to a method of preventing or treating par…
Who is the assignee on this patent?
Mars Inc
What technology area does this patent fall under?
Primary CPC classification A61K36/61. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).